NICE JOB PARTNER!!    ALL READ!!!! To All board

New Post Public Reply Private Reply Replies (0) Message Board
perchy warrior_king #4283

NICE JOB PARTNER!!    ALL READ!!!!

To All board members refrain from using names about others on the other boards, if so, use some asterisks in the subject!

Again, also use asterisks in the foul words, deleted one yesterday, with *ss in it! I know, but it is offensive to a few that take it offensive do to thier beliefs! Please watch your writings and postings! Even use An asterisk in h*ll, which is some what marginal, but from here on out all post with that word in it also will be deleted!

Good board, lets keep it positive and try to refrain about sayings negs about other board! I know, went after a few b8shers myself, mostly for saying poor perchy, LoL!The funny  tx. buffoon hasn't done proper DD, got home and read that! Was gone most of day!  Relax, with those big buys the last few days, I think something coming, 17 and 10 million buys!

Here a little info from me, DD

keep eye on icpa, 2 big buys last two days, one 10 milllions and day before 17 millions at end of days, lots of money buys, my calculations, 88,000.00 and 158,000.00 buys! p.s. should blow real shortly! lots don't understand what this means, IMO, shortly, means real launch is in future!

The company as of this writing May 6th 2012 is in its infancy only a few months into its true launch.


own punch now, fall season here about! look at tv stocks! save some shares for long term!




http://www.profitquotes.com/television-stocks/

Imagination TV, Inc. (IMTV) Stock Research Links

IMTV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading